I suspect biological aging is fundamentally driven by a neuro-somatic feedback loop where the accumulation of double-strand breaks (DSBs) at Common Fragile Sites (CFSs) within large synaptic genes creates a "computational ceiling" on the brain’s predictive depth. This genomic instability doesn't just cause cellular senescence; it physically guts the neural architectures required for high-dimensional future-modeling. As the brain’s internal simulation of the future collapses, it triggers a systemic neuroendocrine transition from long-term somatic maintenance to short-term survivalism, effectively accelerating aging as a response to a perceived "shorter" temporal horizon.

Common Fragile Sites are characterized by their late replication and AT-rich secondary structures, making them hotspots for genomic instability under replication stress. Many of the longest genes in the human genome—those most essential for synaptic scaffolding and long-range connectivity, like NRXN1 or CNTNAP2—overlap with these CFSs.

I'd argue the aging process follows this specific cascade:

1. Selective Erosion of Temporal Circuits: In neurons of the prefrontal cortex and hippocampus, replication stress and DNA damage pile up preferentially in these large, CFS-hosted genes. This selectively degrades the circuits we use for complex Bayesian inference and deep-time future simulation.
2. Predictive Model Collapse: As synaptic reliability wanes, the brain’s "generative model" of the world loses temporal resolution. The subjective experience of aging—that feeling of a shrinking future—is just the cognitive correlate of the brain’s inability to compute stable future states beyond a narrowing window.
3. The Neuro-Somatic Pivot: The brain acts as the body's primary predictive controller. When the internal model predicts a high probability of imminent system failure because of noise in the predictive circuits, the hypothalamus shifts the neuroendocrine profile. Growth hormone (GH) and IGF-1 pathways are downregulated in favor of stress-response pathways like p53/GATA4, which trigger systemic senescence and proteostatic stress.

In this view, the body stops investing in long-term repair not because it can't repair itself, but because the central controller no longer "sees" a future where that investment pays off. Genomic damage at CFSs activates the DNA damage response, which acts as a molecular signal that the temporal horizon is closing.

Recent mapping of gene changes underlying cognitive decline confirms that synaptic plasticity genes are among the first to be downregulated. This isn't a random byproduct of entropy; it's a specific consequence of CFS-targeted damage in large genes required for the "architectural depth" of consciousness. If genomic instability drives neural aging, it does so by breaking the very tools the brain uses to imagine tomorrow.

To test this, we should look for a few specific things:

• Correlation: A direct quantitative link between the rate of DSB accumulation in CFS-hosted synaptic genes (like LSAMP or PTPRD) and an individual’s subjective "future time perspective" (FTP) scores.
• Intervention: Pharmacological stabilization of CFSs in the prefrontal cortex of aged mice shouldn't just improve cognitive function; it should also result in a measurable shift in systemic biomarkers of aging—like reduced p16INK4a in peripheral tissues—by restoring "future-modeling" signals.
• Genomic Architecture: Species with longer lifespans should show evidence of "CFS-shielding," either by moving essential synaptic genes away from fragile sites or by using specialized replication machinery that prevents under-replication in these regions.